{"entity":{"id":"medicare-ncd-110-1","kind":"term","name":"Medicare NCD 110.1: hyperthermia for cancer","aka":["NCD 110.1","Hyperthermia for Treatment of Cancer","Medicare hyperthermia coverage"],"tldr":"Medicare pays for local heat treatment of a tumour only when it is given with radiotherapy for cancers in or just under the skin, not on its own or with chemotherapy.","summary":"United States, Medicare National Coverage Determination 110.1, version 1, effective 31 December 1984. The whole coverage statement: \"Local hyperthermia is covered under Medicare when used in connection with radiation therapy for the treatment of primary or metastatic cutaneous or subcutaneous superficial malignancies. It is not covered when used alone or in connection with chemotherapy.\" The NCD defines local hyperthermia as the use of heat to make tumours more susceptible to cancer therapy.","asOf":"2026-11-04","links":[{"label":"CMS Medicare Coverage Database: the NCD","url":"https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=66&ncdver=1"},{"label":"CMS Coverage API: the NCD text as data","url":"https://api.coverage.cms.gov/v1/data/ncd?ncdid=66&ncdver=1"}],"tags":["us"],"related":[],"cancers":[],"sections":[],"technologies":["hyperthermia","hyperthermia-systems"],"targets":[],"drugs":[],"companies":[],"institutions":["cms"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Regulation & policy"},"route":"/terms/medicare-ncd-110-1/","neighbours":{"technology":[{"id":"hyperthermia","kind":"technology","name":"Hyperthermia","route":"/technologies/hyperthermia/"},{"id":"hyperthermia-systems","kind":"technology","name":"Hyperthermia systems (BSD-2000, EHY-2000, superficial and interstitial applicators)","route":"/technologies/hyperthermia-systems/"}],"institution":[{"id":"cms","kind":"institution","name":"Centers for Medicare & Medicaid Services (CMS)","route":"/institutions/cms/"}]}}